Skip to content
Politically.com Search all
Menu

Final rule 2026-20757

Schedules of Controlled Substances; Removal of Exemption Status for Inactive Butalbital Products

The Drug Enforcement Administration (DEA) is revoking the exempted status for certain nonnarcotic prescription products that are currently on DEA's Table of Exempted Prescription Products, but whose National Drug Codes (NDC) are inactive because they are no longer available and/or the company that applied for the exemption no longer exists. These products will be removed from DEA's Table of Exempted Prescription Products and will no longer be considered exempt prescription products under the Controlled Substances Act. This action does not impact exempted prescription products with active NDC numbers.

Source: FederalRegister.gov API v1Recently refreshed. Last successful refresh: 2026-10-09 08:49:02 UTC.

Source-supplied record

Document details

Document number
2026-20757
Published
Oct 9, 2026
Effective
Nov 9, 2026
Comments close
Not supplied
Federal Register citation
91 FR 64618

Docket identifiers

  • Docket No. DEA-1664

CFR references

  • Title 21, part 1308